GOCO Earnings Prediction
The chart below shows how GOCO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, GOCO sees a +1.15% change in stock price 10 days leading up to the earnings, and a +0.59% change 10 days following the report. On the earnings day itself, the stock moves by +0.48%. This data can give you a slight idea of what to expect for the next quarter's release.
GOCO Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
118.29M
-10.41%
11.73%
Gross Margin
63.48%
15.57%
8.96%
Operating Margin
-35.46%
24.42%
-5.79%
Net Margin
12.99%
130.51%
-123.18%
EPS
0.46
118.25%
-117.04%
No Data Available
GOCO Earnings Analysis
GoHealth, Inc. Class A Common Stock Corporation (GOCO.O) Earnings Conference Call
Positive
Revenue Performance Analysis: GoHealth achieved net revenues of $118.3 million compared to $132 million in the same period last year, indicating strong performance despite market challenges.
Agent Submission Growth: Internal captive agent submissions saw a 46% year-over-year increase, highlighting the effectiveness of enhanced training and targeted marketing efforts.
Acquisition Impact on Finances: The acquisition of e-TeleQuote added approximately $90.5 million in contract assets and $22.5 million in cash to the balance sheet, strengthening GoHealth's financial position.
Positive Cash Flow Increase: The third quarter trailing 12 months had a positive cash flow from operations of $35.1 million, an increase of $38.3 million compared to the previous year.
Cost Management Improvement: GoHealth's direct operating cost per submission was reduced by 11%, demonstrating significant progress in cost management initiatives.
Negative
Net Revenue Decline: GoHealth achieved net revenues of $118.3 million compared to $132 million in the same period last year.
Agent Submission Trends: Internal captive agent submissions saw a 46% year-over-year increase, but submissions from the GPS channel declined by 46%.
Negative EBITDA Decline: Our adjusted EBITDA for the quarter was negative $12.1 million, a slight decrease of $600,000 compared to the prior year.
Cyber Attack Impact on Revenue: The third quarter revenue was impacted by a reduction in revenue of over $8.8 million and earnings by more than $7.8 million due to a cyber attack earlier this year.
Cash Flow Challenges: Despite a strong cash flow from operations of $35.1 million, we still faced challenges in maintaining our financial performance.
GOCO FAQs
How does GOCO typically perform around its earnings report dates?
Is GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
GOCO Earning Call Sentiment
GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
GOCO.O
-1.75%Positive
The earnings call presents a mixed picture. The acquisition of e-TeleQuote and refinancing of the term loan are positive developments. However, the decline in net revenues and adjusted EBITDA, along with the significant impact of a cyber-attack, are concerning. The Q&A section reveals cautious optimism but lacks specific guidance, especially regarding debt targets. The anticipated decline in cash flow from operations also tempers enthusiasm. Overall, the sentiment is balanced by positive strategic moves and operational challenges, leading to a neutral stock price prediction.
